Clinical Trial Update: Diabetes Therapy to Improve BMI and Lung Function in CF [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a diabetes therapy for people with cystic fibrosis has completed, assessing its impact on body mass index and lung function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis, Diabetes Mellitus | Phase 3 | Status: COMPLETED